Parkinsons disease

Industry

-

Muna Therapeutics receives $4.9M grant from the Michael J. Fox Foundation to support the development of Kv1.3 blockers for patients with Parkinson’s disease

Source: Muna Therapeutics

cell

Industry

-

Caraway Therapeutics and AbbVie join forces to develop novel TMEM175 modulators for Parkinson’s disease and other neurodegenerative disorders

Source: Caraway Therapeutics

lysosomes

Industry

-

Caraway Therapeutics receives research grant from the Michael J. Fox Foundation to further study the role of TMEM175 in Parkinson’s disease

Ion Channel library
About
Credits

artem@ionchannellibrary.com

© 2023 Artem Kondratskyi

Terms of Use

Privacy policy